142 related articles for article (PubMed ID: 7885045)
1. RAS and FMS mutations following cytotoxic therapy for childhood acute lymphoblastic leukaemia.
Taylor C; McGlynn H; Carter G; Baker AH; Warren N; Ridge SA; Owen G; Thompson E; Thompson PW; Jacobs A
Leukemia; 1995 Mar; 9(3):466-70. PubMed ID: 7885045
[TBL] [Abstract][Full Text] [Related]
2. RAS mutations in patients following cytotoxic therapy for lymphoma.
Carter G; Hughes DC; Clark RE; McCormick F; Jacobs A; Whittaker JA; Padua RA
Oncogene; 1990 Mar; 5(3):411-6. PubMed ID: 2179819
[TBL] [Abstract][Full Text] [Related]
3. c-fms point mutations in acute myeloid leukemia: fact or fiction?
Springall F; O'Mara S; Shounan Y; Todd A; Ford D; Iland H
Leukemia; 1993 Jul; 7(7):978-85. PubMed ID: 8321048
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia.
Kawamura M; Kikuchi A; Kobayashi S; Hanada R; Yamamoto K; Horibe K; Shikano T; Ueda K; Hayashi K; Sekiya T
Blood; 1995 May; 85(9):2546-52. PubMed ID: 7727782
[TBL] [Abstract][Full Text] [Related]
5. RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia.
Perentesis JP; Bhatia S; Boyle E; Shao Y; Shu XO; Steinbuch M; Sather HN; Gaynon P; Kiffmeyer W; Envall-Fox J; Robison LL
Leukemia; 2004 Apr; 18(4):685-92. PubMed ID: 14990973
[TBL] [Abstract][Full Text] [Related]
6. A C-terminal FMS mutation in a patient with B-cell malignancy.
Baker AH; Ball S; McGlynn H; Whittaker JA; Burnett AK; Padua RA
Leukemia; 1995 Jan; 9(1):155-8. PubMed ID: 7845011
[TBL] [Abstract][Full Text] [Related]
7. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
[TBL] [Abstract][Full Text] [Related]
8. FMS mutations in patients following cytotoxic therapy for lymphoma.
Baker A; Cachia P; Ridge S; McGlynn H; Clarke R; Whittaker J; Jacobs A; Padua RA
Leuk Res; 1995 May; 19(5):309-18. PubMed ID: 7769831
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
[TBL] [Abstract][Full Text] [Related]
10. K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements.
Liang DC; Shih LY; Fu JF; Li HY; Wang HI; Hung IJ; Yang CP; Jaing TH; Chen SH; Liu HC
Cancer; 2006 Feb; 106(4):950-6. PubMed ID: 16404744
[TBL] [Abstract][Full Text] [Related]
11. [N-ras and fms gene mutation in idiopathic thrombocytopenic purpura and myelodysplasia].
Zhao HY; Hou M; Li XF; Ma DX; Liu QJ; Wang P
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):158-60. PubMed ID: 18788612
[TBL] [Abstract][Full Text] [Related]
12. Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia.
Christiansen DH; Andersen MK; Desta F; Pedersen-Bjergaard J
Leukemia; 2005 Dec; 19(12):2232-40. PubMed ID: 16281072
[TBL] [Abstract][Full Text] [Related]
13. Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Shu XO; Perentesis JP; Wen W; Buckley JD; Boyle E; Ross JA; Robison LL;
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1230-5. PubMed ID: 15247135
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the ras genes is a rare genetic event in the histologic transformation of follicular lymphoma.
Clark HM; Yano T; Sander C; Jaffe ES; Raffeld M
Leukemia; 1996 May; 10(5):844-7. PubMed ID: 8656681
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between N-ras gene mutations and clinical prognosis in Brazilian children with acute lymphoblastic leukemia.
Clementino NC; Yamamoto M; Viana MB; Figueiredo MS; Kerbauy J; Saad ST; Costa FF
Leuk Lymphoma; 2001 Jul; 42(3):473-9. PubMed ID: 11699412
[TBL] [Abstract][Full Text] [Related]
17. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia.
Jacobson DR; Mills NE
Oncogene; 1994 Feb; 9(2):553-63. PubMed ID: 8290266
[TBL] [Abstract][Full Text] [Related]
18. Lack of TP53 and FMS gene mutations in children with myelodysplastic syndrome.
Jekic B; Novakovic I; Lukovic L; Kuzmanovic M; Popovic B; Milasin J; Bunjevacki G; Damnjanovic T; Cvjeticanin S; Bunjevacki V
Cancer Genet Cytogenet; 2006 Apr; 166(2):163-5. PubMed ID: 16631474
[TBL] [Abstract][Full Text] [Related]
19. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of K-ras codon 12 in blood samples of patients with acute myeloid leukemia.
Preston R; Däbritz J; Hänfler J; Oettle H
Leuk Res; 2010 Jul; 34(7):883-91. PubMed ID: 20304488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
